Get started
Author

Tatiana S. Кruglova

Observed names: T. S. Kruglova, Tatiana Kruglova, Tatiana S. Kruglova, Tatyana S. Kruglova, Tatyana S. Кruglova, Т. S. Kruglova
ORCID: 0000-0002-4949-9178
Observed ORCID: 0000-0002-4949-9178
OpenAlex ID: A5086925244
Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals
2021 · Oleg Melikhov, Tatiana Kruglova, et al. · Annals of the Rheumatic Diseases · 11
PDF
Comparative analysis of tocilizumab in severe COVID-19-associated pneumonia in patients of different age groups
2020 · D. S. Fomina, N. G. Poteshkina, et al. · PULMONOLOGIYA · 11
PDF
Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids
2023 · Ekaterina A. Nikitina, Daria S. Fomina, et al. · Frontiers in Medicine · 7
PDF
Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies
2023 · Anna A. Roppelt, Marina S. Lebedkina, et al. · Terapevticheskii arkhiv · 7
PDF
Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment
2022 · Alexey I. Khripun, Andrey V. Starshinin, et al. · Terapevticheskii arkhiv · 6
PDF
Baricitinib in the Treatment of Patients with COVID-19: A Review of International Data and Analysis of Clinical Results in the Russian Population
2021 · А. I. Zagrebneva, Е. А. Baryakh, et al. · Antibiot Khimioter = Antibiotics and Chemotherapy · 4
PDF
Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression
2023 · D. S. Fomina, S. S. Andreev, et al. · PULMONOLOGIYA · 3
PDF
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit
2022 · Ulyana A. Mаrkina, Daria S. Fomina, et al. · Terapevticheskii arkhiv · 3
PDF
Clinical and anamnestic analysis of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis hospitalised in Moscow. Development of a prognostic model of unfavourable outcomes
2025 · Ekaterina A. Nikitina, Alexander D. Dushkin, et al. · Russian Journal of Allergy · 1
ASIA syndrome masked as recurrent angioedema: сan development be predicted by genetic screening (pilot study)
2025 · Darya S. Fomina, Marina S. Lebedkina, et al. · Russian Journal of Allergy · 1
PDF
New coronavirus infection SARS-CoV-2 in adult patients with inborn errors of immunity
2024 · Anna A. Roppelt, Ulyana A. Mаrkina, et al. · Russian Journal of Allergy · 1
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting
2022 · Tatiana S. Kruglova, Daria S. Fomina · Terapevticheskii arkhiv · 1
PDF
Drug-induced sarcoidosis-like syndrome associated with anti-IL-4, -13 inhibitor therapy in a patient with T2-associated comorbidities: clinical case
2026 · N. A. Kuleshova, O. A. Mukhina, et al. · PULMONOLOGIYA
PDF
Still’s disease in a patient with common variable immunodeficiency: NFKB1 defect
2025 · Anna A. Roppelt, Еkaterina A. Nikitaeva, et al. · Russian Journal of Allergy
Artificial intelligence tools for phenotyping patients with anaphylaxis
2025 · Ekaterina A. Nikitina, Alexander D. Dushkin, et al. · Russian Journal of Allergy
Recurrent angioedema with normal C1-inhibitor: genetics determine the endotype
2025 · Marina S. Lebedkina, Darya S. Fomina, et al. · Russian Journal of Allergy
Физиолого-биохимический статус собак в норме и при левожелудочковой диастолической дисфункции
2014 · Tatiana S. Кruglova, И А Пахмутов · CyberLeninK (CyberLeninka)
Works count: 17
Citation count: 56
H-index: 5
I10-index: 2
Year
Topic
Type